ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,402, issued on June 3, was assigned to AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Suwon-si, South Korea).

"Composition for treating or preventing colitis by NAMPT metabolic regulation" was invented by You-Sun Kim (Suwon-si, South Korea), Sun Mi Hong (Suwon-si, South Korea) and A-Yeon Lee (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a pharmaceutical composition for treating or preventing inflammatory diseases including nicotinamide mononucleotide (NMN) as an active ingredient. When NAMPT was knocked out, removal of dead cells for tissue repair was failed, which leads to a significa...